Literature DB >> 12576877

Amphetamine withdrawal does not produce a depressive-like state in rats as measured by three behavioral tests.

H Russig1, M-A Pezze, N I Nanz-Bahr, C R Pryce, J Feldon, C A Murphy.   

Abstract

Administration of amphetamine (AMPH) can induce symptoms of psychosis in humans and locomotor sensitization in rats; in contrast, withdrawal from a period of AMPH intake is most often associated with symptoms of human endogenous depression. The aim of this study was to determine whether AMPH withdrawal produces a depressive-like state in rats. The present study examined the effects of withdrawal from an escalating-dose AMPH schedule (ESC; three daily injections over 6 days, 1-5 mg/kg, i.p.) and an intermittent-dose AMPH schedule (INT; one daily injection over 6 days, 1.5 mg/kg, i.p.) on animals' performance in three behavioral paradigms related to depression: the Porsolt swim test, the learned helplessness assay and operant responding for sucrose on a progressive ratio schedule. ESC and INT AMPH withdrawal had no effect on any of these tests or on stress responsiveness as measured by increased plasma levels of corticosterone (CORT) and adrenocorticotropin following the swim test, although basal CORT levels were higher in AMPH-withdrawn animals compared to controls. Finally, we confirmed the presence of locomotor sensitization for both AMPH schedules after 30 days of withdrawal. Our results suggest that the ability of AMPH withdrawal to produce symptoms of depression may not be evident in all behavioral screens for depressive symptoms in the rat.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12576877     DOI: 10.1097/00008877-200302000-00001

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  12 in total

1.  Pre- and/or postnatal protein restriction in rats impairs learning and motivation in male offspring.

Authors:  L A Reyes-Castro; J S Rodriguez; G L Rodríguez-González; R D Wimmer; T J McDonald; F Larrea; P W Nathanielsz; E Zambrano
Journal:  Int J Dev Neurosci       Date:  2010-11-13       Impact factor: 2.457

2.  Withdrawal from repeated amphetamine administration leads to disruption of prepulse inhibition but not to disruption of latent inhibition.

Authors:  D Peleg-Raibstein; E Sydekum; H Russig; J Feldon
Journal:  J Neural Transm (Vienna)       Date:  2005-12-16       Impact factor: 3.575

3.  Withdrawal from chronic exposure to amphetamine, but not nicotine, leads to an immediate and enduring deficit in motivated behavior without affecting social interaction in rats.

Authors:  Andre Der-Avakian; Athina Markou
Journal:  Behav Pharmacol       Date:  2010-07       Impact factor: 2.293

4.  Withdrawal from fixed-dose injection of methamphetamine decreases cerebral levels of 3-methoxy-4-hydroxyphenylglycol and induces the expression of anxiety-related behavior in mice.

Authors:  Nobue Kitanaka; Junichi Kitanaka; Tomohiro Tatsuta; Koh-ichi Tanaka; Kaname Watabe; Nobuyoshi Nishiyama; Yoshio Morita; Motohiko Takemura
Journal:  Neurochem Res       Date:  2010-02-11       Impact factor: 3.996

Review 5.  Encore: Behavioural animal models of stress, depression and mood disorders.

Authors:  Aleksa Petković; Dipesh Chaudhury
Journal:  Front Behav Neurosci       Date:  2022-08-08       Impact factor: 3.617

6.  Transient disruption of attentional performance following escalating amphetamine administration in rats.

Authors:  Robyn L Kondrad; Joshua A Burk
Journal:  Psychopharmacology (Berl)       Date:  2004-10       Impact factor: 4.530

7.  Withdrawal from continuous amphetamine administration abolishes latent inhibition but leaves prepulse inhibition intact.

Authors:  Daria Peleg-Raibstein; Esther Sydekum; Holger Russig; Joram Feldon
Journal:  Psychopharmacology (Berl)       Date:  2006-02-10       Impact factor: 4.530

8.  Recapitulation and reversal of a persistent depression-like syndrome in rodents.

Authors:  Shannon L Gourley; Jane R Taylor
Journal:  Curr Protoc Neurosci       Date:  2009-10

Review 9.  Neurochemical consequences of dysphoric state during amphetamine withdrawal in animal models: a review.

Authors:  Junichi Kitanaka; Nobue Kitanaka; Motohiko Takemura
Journal:  Neurochem Res       Date:  2007-06-29       Impact factor: 3.996

10.  Derivation and validation of murine histologic alterations resembling asthma, with two proposed histologic grade parameters.

Authors:  Mitchell S Wachtel; Goutam Shome; Mhairi Sutherland; John J McGlone
Journal:  BMC Immunol       Date:  2009-10-30       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.